Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00768573 · ClinicalTrials.gov registry record

Taste Test of a New Formulation of Sildenafil (Revatio)

A clinical trial, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris.

Completed
Registry status
4
Enrollment target

NCT00768573 is a clinical trial that has completed, run by Pfizer's Upjohn has merged with Mylan to form Viatris. The registered enrollment target is 4 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00768573 has completed, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris.

COMPLETED
Registry status
4 participants
Enrollment target

Study Summary

taste of formulation

Interventions

  • DRUG sildenafil

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2008-01
Est. Completion 2008-01

What the Registry Record Tells You About NCT00768573

The ClinicalTrials.gov registry entry for NCT00768573 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer's Upjohn has merged with Mylan to form Viatris, which has 158 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which sildenafil is the first listed.

NCT00768573 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00768573 about?

NCT00768573 is a clinical study titled "Taste Test of a New Formulation of Sildenafil (Revatio)". taste of formulation

What is the current status of trial NCT00768573?

This trial is currently completed. The enrollment target is 4 participants. The study started on 2008-01. Estimated completion is 2008-01.

What interventions are being tested in trial NCT00768573?

The interventions under investigation include: sildenafil (DRUG).

Who is sponsoring clinical trial NCT00768573?

This trial is sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris, which has 158 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.